Highlights and Quick Summary
- Retained Earnings for the quarter ending February 28, 2022 was $-221 Million (a 2.26% increase compared to previous quarter)
- Year-over-year quarterly Retained Earnings increased by 7.23%
- Annual Retained Earnings for 2021 was $-219 Million (a 97.72% increase from previous year)
- Annual Retained Earnings for 2020 was $-111 Million (a 1575.43% increase from previous year)
- Annual Retained Earnings for 2019 was $-6.6 Million (a -1231.08% decrease from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Retained Earnings of Organigram Holdings Inc.
Most recent Retained Earningsof OGI including historical data for past 10 years.Interactive Chart of Retained Earnings of Organigram Holdings Inc.
Organigram Holdings Inc. Retained Earnings for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-221.26 | – | – | – | – |
| 2021 | $-216.37 | $-218.77 | $-206.34 | $-194.97 | $-218.77 |
| 2020 | $-136.16 | $-107.82 | $-76.1 | $-12.51 | $-110.64 |
| 2019 | $-7.3 | $-6.63 | $10.2 | $17.9 | $-6.6 |
| 2018 | – | – | $23.11 | $0.59 | $0.58 |
| 2017 | – | – | – | – | $-15.56 |
| 2016 | – | – | – | – | $-6.77 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic